Paul Harrison

I trained in medicine and psychiatry in Oxford and London, and was a Wellcome Trust Senior Research Fellow before being appointed to my present post in 1997. I head a research group investigating molecular, psychopharmacological and therapeutic aspects of mood disorders and schizophrenia - and, more recently, the psychiatric and neurological consequences of COVID-19. I have published over 320 papers and several books, including Shorter Oxford Textbook of Psychiatry, and Schizophrenia (with Daniel Weinberger). I am a Theme Leader in the NIHR Oxford Health Biomedical Research Centre, and an investigator in the Wellcome Centre for Integrative Neuroimaging. I am a Deputy Editor for Biological Psychiatry. Awards include the CINP/Paul Janssen Schizophrenia Prize (1998), the British Association for Psychopharmacology Senior Clinical Prize (1999), the A.E. Bennett Award of the Society of Biological Psychiatry (2004), the Joel Elkes Research Award of the American College of Neuropsychopharmacology (2005), the CINP Lilly Clinical Neuroscience award (2010), and the ECNP Clinical Neuropsychopharmacology award (2012). I was President of the British Association for Psychopharmacology from 2014-2016.